Supernova 2

Supernova Invest, established in 1999, is a Paris-based private equity and venture capital firm with additional offices in Grenoble. It manages a €800m fund, Supernova 2, founded in 2017. The firm specializes in early-stage investments, focusing on deep technology companies across sectors such as healthcare, industry 4.0, energy & environment, and digital technologies. It provides patient capital and expertise to support high-growth startups, with a track record of successful exits through IPOs and M&As. Supernova Invest partners with CEA Investissement to offer startups access to the CEA network and services.

Cécile Benet

Investment Director

Lucille Benoît

Analyst

Alexandre Biau

Investment Director

Alexandre Biau

Investment Director

Damien Bretegnier

Investment Director

Pascal-André Chenal

Investment Manager

Alexandre Cordier

Analyst

Arthur Falinower

Analyst

Marine Glon

Investment Director

Celia Hart Ph.D

General Partner

Claude-Sebastien Lerbourg

Investment Director

Etienne Moreau

Partner

Arthur Puig

Associate

Régis Saleur

Managing Partner

Romain Sautrau

Investment Director

Remi Spagnol

Investment Director

Pierre-Emmanuel Struyven

Managing Partner

Michael Thomas

Investment Director

Nicolas Topuz

Analyst

Gregoire Viot

CFO

Claude-Sebastien Lerbourg

Investment Director

Pascal-andré Chenal

Investment Director

82 past transactions

mirSense

Series A in 2025
mirSense develops Quantum Cascade Lasers (QCL) and QCL-based spectrometer modules for gas analysis. Its products enable industries and defense sectors to monitor and control gas emissions, improve air quality, and enhance medical treatment accuracy.

Galam Robotics

Series A in 2025
Galam Robotics develops modular robotic solutions to optimize logistics and storage processes. The technology enhances productivity and compactness of stores and logistics hubs, transforming storage into constrained spaces to improve handling flows at high density and speed, enabling businesses with complex needs to optimize storage capacity and throughput.

Fyteko

Series B in 2025
Fyteko is an agtech company headquartered in Brussels, founded in 2014, that develops and produces advanced plant biostimulants. Its flagship product is a biomolecule that enhances crop resilience to both biotic and abiotic stresses, allowing farmers to increase productivity and quality while reducing environmental impact.

Enduro Genetics

Series A in 2025
Enduro Genetics is a technology provider that specializes in enhancing large-scale fermentations through its proprietary synthetic biology technology. The company focuses on improving the performance of fermentation processes by developing a genetic plugin technology that is free of antibiotic resistance genes. This innovation allows for higher yields by enriching spontaneous high producers within the fermentation population, facilitating the production of complex or cellular inhibit products by addressing strain instability. By maximizing the performance of cells derived from production strains, Enduro aims to bolster the competitiveness of both current and future green bioproduction initiatives.

Alice & Bob

Series B in 2025
Alice & Bob is a Paris-based quantum computing hardware company founded in 2020. It develops universal quantum computers designed to enable industries and researchers to tackle complex problems. The company focuses on integrating error correction into its hardware, using cat qubits with built-in error resilience, and provides a platform with cloud access for remote testing and expert support. This combination aims to deliver early quantum computational advantages for practical applications in science and industry.

Capra Robotics

Seed Round in 2025
Capra Robotics specializes in the development of outdoor mobile robots. Its patented platform enables enhanced mobility for users with varying physical abilities.

Loft Orbital

Series C in 2025
Loft Orbital Solutions Inc. is a company based in San Francisco, California, that provides comprehensive services for the deployment and operation of customer payloads in space. Established in 2017, Loft Orbital specializes in operating microsatellites and offers an end-to-end solution that includes satellite platform integration, launch booking, and operational management. The company simplifies the satellite deployment process by utilizing a standardized satellite bus and a suite of software tools, thereby reducing costs and accelerating the timeline to orbit. Additionally, Loft Orbital addresses financial and regulatory challenges by providing solutions for licensing, insurance, and financing, allowing customers to concentrate on their mission objectives rather than the technical complexities of satellite engineering.

ANYbotics

Series B in 2024
Founded in 2016, ANYbotics develops autonomous legged robots designed for industrial applications. These robots are equipped with features such as docking stations, robust sensing capabilities, and waterproofing. They also offer tools for reading instruments, monitoring equipment health, detecting events, and inspecting complex environments. The company aims to improve worker safety, increase productivity, and support sustainable operations in industries like oil and gas, power, mining, chemicals, construction, and transportation.

DessIA

Venture Round in 2024
DessIA develops artificial intelligence-augmented engineering software that automates engineering tasks. The platform provides AI-powered bots that assist engineers in the early stages of product development, quickly generating thousands of architectural options and identifying configurations that satisfy sustainability and profitability criteria. By reducing development lead times, the software helps automotive and mechanical engineers optimize designs and explore innovative approaches to engineering challenges.

Discure Technologies

Series A in 2024
Discure Technologies develops a minimally invasive implantable bioelectronic device designed to treat and reverse degenerative disc disease. The device aims to heal the intervertebral disc, reduce pain, and restore function by actively managing the reintroduction of fluids, oxygen, and nutrients into the degenerated disc, with the goal of reducing reliance on opioids and invasive back surgery.

Wattalps

Series A in 2024
Wattalps is a technology company specializing in the development of lithium power systems tailored for small and medium-scale applications. Their product portfolio focuses on affordability, passive safety measures, efficient cooling mechanisms, extended lifespan, and robust cell protection features. Wattalps aims to simplify integration into vehicles or charging stations by offering standard and modular products, thereby facilitating swift, efficient, and cost-effective adoption of electric vehicle technologies and sustainable transportation solutions.

Micropep

Series B in 2024
Micropep Technologies is an agricultural biotechnology company founded in 2016 and based in Toulouse, France. The company specializes in the development of non-GMO bioherbicides and biostimulants utilizing its innovative miPEP technology, which harnesses naturally-occurring micro-peptides to regulate gene expression and enhance plant growth. Micropep focuses on four key development programs: germination, flowering, growth, and weed control, aiming to improve agricultural yields while maintaining the integrity of plant DNA. By leveraging the potential of these biomimetic peptides, Micropep seeks to provide effective solutions for managing plant genetics and enhancing resistance to diseases, thereby supporting sustainable farming practices.

UroMems

Series C in 2024
UroMems is a medical device company dedicated to addressing specific clinical needs related to urinary conditions that significantly impact patients' quality of life. The company specializes in the design, development, and commercialization of active implantable medical devices. Its innovative approach aims to enhance existing surgical treatments by minimizing associated side effects and ensuring that patients receive appropriate care promptly. Through its commitment to improving treatment options, UroMems seeks to benefit a wide range of patients facing urinary health challenges.

Seederal

Series A in 2024
Seederal Technologies is a manufacturer specializing in agriculture, construction, and mining machinery, with a focus on innovative medium-power electric tractors. The company designs tractors that deliver 160 horsepower using electric motors, aiming to minimize the environmental impact associated with traditional agricultural equipment. By providing a more sustainable option, Seederal seeks to reduce the overall cost of ownership for farmers, allowing them to benefit from the efficiency and autonomy of electric tractors while maintaining the power equivalent to conventional models.

Diabeloop

Venture Round in 2024
Diabeloop is a medical device company based in Grenoble, France, specializing in innovative solutions for diabetes management. Founded in 2015, the company focuses on developing a closed-loop system that automates insulin delivery for individuals with type 1 diabetes. Its AI-based blood sugar monitoring device integrates a sensor that continuously measures glucose levels, a pump that administers insulin, and a smartphone application that connects these components through an embedded algorithm. This technology aims to enhance the treatment experience by reducing the mental burden on patients, allowing them to manage their condition more effortlessly and live their lives with greater freedom.

Wise Integration

Series B in 2024
Wise Integration is a developer of GaN-integrated solutions to miniaturize power supplies and improve energy efficiency.

Unseenlabs

Series C in 2024
Founded in 2015, Unseenlabs specializes in marine surveillance services. It designs and develops satellite payloads to detect and track non-cooperative vessels worldwide, even when they disable their Automatic Identification System. The company offers turnkey solutions, providing information from satellite design to launch.

Cambridge Mechatronics

Venture Round in 2024
Cambridge Mechatronics is a high-technology design and engineering company based in Cambridge, United Kingdom. It specializes in developing mechatronic platform technology from concept to mass production, offering actuators made from shape memory alloy for applications requiring compact, high-precision motion. Its products include OIS actuators for smartphone cameras, autofocus actuators for high-resolution cameras, and digital sound projectors that steer sound beams for immersive listening. The company also develops Dynasonix 3D audio products. Cambridge Mechatronics pursues technology licensing and partnerships with global manufacturers to bring its innovations to market, supported by an extensive portfolio of granted patents. By integrating smart materials, miniature motors, and advanced control, it enables customers to achieve precise actuation in small form factors. The firm focuses on delivering reliable, high-performance mechatronic solutions across mobile, consumer electronics, and related sectors.

Vulkam

Venture Round in 2023
Vulkam SAS is a microtechnology company based in Saint-Martin-d'Hères, France, specializing in the design and production of amorphous metal parts. Founded in 2017, Vulkam focuses on creating biocompatible amorphous metal alloys primarily composed of zirconium, copper, hafnium, nickel, and titanium. The company's innovative products serve various industries, including aerospace, automotive, biomedical, and microcomponents. Vulkam's micromechanical parts are notable for their small size and exceptional strength, offering performance comparable to established industry standards. By leveraging advanced materials science, Vulkam aims to set new benchmarks in metallurgy and metal processing, catering to the growing demand for high-performance, functional components in diverse applications.

Carthera

Series B in 2023
Carthera is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices for treating brain disorders. Its proprietary device, SonoCloud®, is an intracranial ultrasound implant that, when used in conjunction with an intravenous microbubble agent, temporarily opens the blood-brain barrier. This mechanism significantly enhances the delivery of therapeutic molecules to the brain, potentially providing new treatment options for debilitating neurological conditions. Through its technology, Carthera aims to enable healthcare professionals to address challenging brain disorders more effectively.

Adionics

Series B in 2023
Adionics is a Paris-based technology company focused on saline water valorization and desalination. It develops and commercializes processes and chemicals for removing salts from saline sources, including AquaOmnes, a water-desalination technology that extracts salt from salty water to leave fresh water, and Flionex, an ion-absorbing liquid that binds salts. The company serves municipal water, power, oil and gas, and chemical markets. It also develops FLIONEX, a selective extractant for lithium salts, and pursues research to enable lithium recycling from batteries. Its saline water treatment platform uses a chemical-free liquid-liquid extraction with hot water stripping to recover lithium, valuable minerals, or remove impurities from brine, seawater and other saline sources, aiming for cost-effective, low-environmental impact solutions.

EODev

Series A in 2023
EODev is a company focused on accelerating the energy transition through innovative hydrogen generation technology. The firm develops a range of products and services aimed at providing sustainable and efficient energy solutions. Their offerings include an energy designer, a hydrogen generator, and a navigation range extender, all of which enable various sectors to access clean and renewable energy alternatives to fossil fuels. By promoting the use of hydrogen as an energy source, EODev is committed to creating dependable and cost-effective solutions that support the transition towards a more sustainable energy landscape.

Aledia

Venture Round in 2023
Founded in 2011, Aledia specializes in the development and manufacturing of innovative light-emitting diodes (LEDs) based on a unique 3D architecture using gallium-nitride-on-silicon microwires. This technology enables efficient, brighter, and cost-effective displays for various applications such as general lighting, automotive, displays, smartphones, smartwatches, tablets, and laptops.

Quobly

Seed Round in 2023
Quobly develops semiconductor-based technologies for large-scale quantum computing, aiming to unlock the full potential of quantum technologies. The company focuses on a fault-tolerant approach using established semiconductor fabrication methods.

Allotex

Series B in 2023
Allotex, Inc. is an ophthalmic biologics and device company based in Boston, Massachusetts. Founded in 2013, it specializes in the development of innovative contact lenses and therapeutic solutions aimed at addressing refractive vision issues such as presbyopia, hyperopia, and myopia. Allotex utilizes precisely-shaped human corneal allografts in conjunction with a compact excimer laser system to create permanent, living contact lenses or lens inserts. This approach allows medical professionals to provide the least invasive treatment options for various refractive procedures, enhancing patient outcomes in vision correction.

Gleamer

Series B in 2023
Gleamer develops AI-powered radiology software that acts as an automated second reader within clinicians' standard imaging workflows. Its AI companions automatically detect bone abnormalities and lesions on X-ray exams, highlighting findings and providing preliminary data to support diagnoses, speeding interpretation and helping radiologists prioritize patients. The tools integrate into routine reading environments and are deployed across multiple countries and institutions to improve diagnostic accuracy and efficiency in trauma and general radiography.

Carthera

Series B in 2023
Carthera is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices for treating brain disorders. Its proprietary device, SonoCloud®, is an intracranial ultrasound implant that, when used in conjunction with an intravenous microbubble agent, temporarily opens the blood-brain barrier. This mechanism significantly enhances the delivery of therapeutic molecules to the brain, potentially providing new treatment options for debilitating neurological conditions. Through its technology, Carthera aims to enable healthcare professionals to address challenging brain disorders more effectively.

BeFC Bioenzymatic Fuel Cells

Series A in 2023
BeFC Bioenzymatic Fuel Cells is a company based in Grenoble, France, that specializes in the development of ecological devices, specifically paper-based bioenzymatic fuel cells. Founded in 2020, BeFC focuses on providing sustainable and eco-friendly energy solutions aimed at minimizing environmental impact. Their innovative technology features ultra-thin, flexible, and miniature fuel cells designed to replace traditional button or coin cell batteries, which are often difficult to recycle and environmentally harmful. By offering a safe alternative, BeFC facilitates the advancement of disposable and wearable medical devices, as well as low-power applications in health monitoring, logistics, and the Internet of Things (IoT). The company's approach not only addresses existing energy needs but also opens up new opportunities in various sectors.

ProovStation

Series A in 2023
ProovStation is a DeepTech start-up that operates in 13 European countries, focusing on automating and standardizing the automotive inspection process through advanced computer vision technology. Established in 2017, the company aims to enhance efficiency and reduce costs associated with vehicle inspections. ProovStation has developed a series of high-tech vehicle scanners that perform a 360-degree scan of vehicles in just three seconds, utilizing an array of optical technologies to analyze damages down to a millimeter scale. The system employs artificial intelligence to detect, measure, and locate these damages, generating a secure, time-stamped, and geolocated report. In addition to the inspection technology, ProovStation offers customers a suite of software-as-a-service solutions, including automatic reconditioning quotes, vehicle pricing for resale, and various management tools designed to streamline the inspection and reconditioning processes.

SoniVie

Series C in 2023
SoniVie is a medical device company focused on developing innovative solutions for the treatment of pulmonary hypertension. The company has created a minimally invasive denervation device that is designed to be inserted into the pulmonary artery through a catheterization procedure. This advanced technology selectively targets and damages the nerves associated with pulmonary hypertension, while preserving the integrity of the vessel walls and surrounding tissues. By enabling physicians to perform denervation procedures with greater precision, SoniVie aims to improve treatment options and outcomes for patients suffering from this serious condition.

Remedee Labs

Series A in 2022
Remedee Labs SAS is a French company founded in 2016, dedicated to developing innovative solutions for chronic pain management. The company has created the Microelectronic Endorphin Trigger (MEET), a personal endorphin stimulator that facilitates on-demand stimulation of the body’s natural endorphins to alleviate pain. Drawing on a decade of pre-clinical and clinical research, Remedee Labs aims to improve the quality of life for the 1.5 billion people worldwide suffering from chronic pain, particularly focusing on conditions such as fibromyalgia. By collaborating with medical practitioners, the company offers a patient-centered digital service platform that enhances the accessibility and effectiveness of endorphin-stimulation therapy for personal healthcare. As it continues to evolve, Remedee Labs plans to expand its platform to address additional chronic pain conditions, positioning itself as a leader in neuromodulation technology for pain management.

Aniah

Series A in 2022
Aniah is a company that specializes in providing an integrated circuit (IC) verification tool designed to eliminate electrical errors in chip designs. The platform conducts electrically accurate analyses at the transistor level, allowing for the detection of errors across the entire IC in a single run. This capability enables users to focus on correcting genuine errors rather than sifting through false positives, thereby enhancing the efficiency of the design process. Aniah's technology delivers relevant results in seconds, facilitating continuous design improvements and expediting the sign-off process for semiconductor projects. By integrating this verification tool, companies and engineers can maintain a higher level of accuracy and vigilance during complex workflow scenarios.

CrowdSec

Series A in 2022
CrowdSec is an open-source cybersecurity platform that specializes in analyzing visitor behavior to enhance online security. The company’s software provides real-time threat detection and security automation, allowing users to respond effectively to various types of attacks. By leveraging a community-driven approach, CrowdSec enables its users to share information about blocked IP addresses, thereby enhancing collective security measures across the internet. Its focus on behavior analysis and data breach prevention positions CrowdSec as a valuable resource for organizations seeking to protect their digital assets from emerging threats.

Prophesee

Series C in 2022
Prophesee develops neuromorphic vision systems that mimic the human eye's functionality. Its patented sensors and AI algorithms enable unprecedented speed (>10,000 fps), dynamic range (>120dB), data volume reduction (10x to 1000x), and power efficiency (<10 mW). Prophesee serves clients in autonomous driving, mobile devices, IoT, and industry sectors. Founded in Paris in 2014 by Ryad Benosman, Bernard Gilly, Christoph Posch, and Luca Verre, the company is backed by leading international investors.

Moments Lab

Series A in 2022
Moments Lab empowers content producers worldwide by streamlining video creation workflows. Its platform, powered by MXT Multimodal AI, makes audiovisual content searchable and accessible, reducing time spent on sourcing key moments. This enables professionals to focus on creativity and higher-value decisions. The company offers four solutions: Just Index for metadata extraction, Media Hub for innovative media asset management, Live Asset Manager for real-time live stream access, and Media Marketplace for white-label storefronts to monetize media libraries.

Micropep

Series A in 2022
Micropep Technologies is an agricultural biotechnology company founded in 2016 and based in Toulouse, France. The company specializes in the development of non-GMO bioherbicides and biostimulants utilizing its innovative miPEP technology, which harnesses naturally-occurring micro-peptides to regulate gene expression and enhance plant growth. Micropep focuses on four key development programs: germination, flowering, growth, and weed control, aiming to improve agricultural yields while maintaining the integrity of plant DNA. By leveraging the potential of these biomimetic peptides, Micropep seeks to provide effective solutions for managing plant genetics and enhancing resistance to diseases, thereby supporting sustainable farming practices.

SCINTIL Photonics

Venture Round in 2022
SCINTIL Photonics is a fabless company focused on silicon photonics, developing silicon photonic integrated circuits. It combines silicon and indium phosphide materials using wafer-scale bonding to create fully integrated photonic circuits, including multi-wavelength lasers, waveguides, wavelength filters, and photodetectors, designed for high-speed data communication. The company relies on commercial silicon foundry processes and offers co-packaged and pluggable formats to enhance AI data center bandwidth and performance. Headquartered in Grenoble, France.

Diabeloop

Series C in 2022
Diabeloop is a medical device company based in Grenoble, France, specializing in innovative solutions for diabetes management. Founded in 2015, the company focuses on developing a closed-loop system that automates insulin delivery for individuals with type 1 diabetes. Its AI-based blood sugar monitoring device integrates a sensor that continuously measures glucose levels, a pump that administers insulin, and a smartphone application that connects these components through an embedded algorithm. This technology aims to enhance the treatment experience by reducing the mental burden on patients, allowing them to manage their condition more effortlessly and live their lives with greater freedom.

UnitySC

Venture Round in 2022
UnitySC is a globally recognized leader in inspection and metrology, specializing in advanced technologies such as automated optical inspection and 3D imaging. By offering customized solutions tailored to specific industrial requirements, UnitySC empowers customers to enhance yields and accelerate time to market. Through innovative techniques like high depth of focus line scanning and spectrometry, UnitySC enables a new era in process control, facilitating efficient and precise manufacturing operations.

Cairdac

Series A in 2022
Cairdac is a medical technology company developing a self-sustaining, leadless pacing system. Its proprietary piezoelectric energy harvester and miniaturized ASIC enable the device to harvest kinetic energy from the heart, providing a lifespan of over 15 years. The ALPSTM pacemaker is autonomously implanted via endoscopy, offering a cost-effective solution for maintaining cardiac rhythm.

Terakalis

Series A in 2022
Terakalis is a company that specializes in the development of non-destructive testing equipment for the analysis and control of materials and industrial processes. Established through a technological partnership with the Charles Coulomb laboratory in 2012, Terakalis focuses on TeraHertz electromagnetic waves, which range from 100 GHz to 10 THz. The company's offerings include a variety of both generic and custom-made products and systems designed to inspect materials for internal defects and to characterize their physical and chemical properties. By providing integrated line-of-production equipment and portable alternatives, Terakalis enhances operational efficiency for businesses across various sectors.

Alice & Bob

Series A in 2022
Alice & Bob is a Paris-based quantum computing hardware company founded in 2020. It develops universal quantum computers designed to enable industries and researchers to tackle complex problems. The company focuses on integrating error correction into its hardware, using cat qubits with built-in error resilience, and provides a platform with cloud access for remote testing and expert support. This combination aims to deliver early quantum computational advantages for practical applications in science and industry.

Aleph Zero

Seed Round in 2022
Aleph Zero is a scalable, fast, and developer-friendly proof-of-stake blockchain platform. It offers private smart contracts, high speed transactions, and privacy-enhancing features based on secure multi-party computation research.

Traxens

Venture Round in 2022
Traxens is a provider of supply chain tracking services that offers comprehensive data and analytics to enhance visibility into container transport and logistics. The company focuses on delivering precise and timely information on containers and their transporters, enabling stakeholders in multi-modal transport to improve operational efficiency, reduce costs, and optimize investments. Through a dedicated three-year research and development program, Traxens has developed advanced technology for cost-effective, durable, and autonomous devices capable of capturing and transmitting real-time data from anywhere in the world. This innovative approach allows Traxens to transform logistics data into actionable insights, benefiting a wide range of customers in the supply chain industry.

NAWA Technologies

Series C in 2022
NAWA Technologies specializes in developing advanced energy storage solutions, focusing on its innovative Ultra Fast Carbon Battery Technology. Founded in April 2013 and supported by over 15 years of research and development in nanomaterials, the company aims to enhance energy conversion, storage, transport, and efficiency using carbon, which is abundant and environmentally friendly. NAWA Technologies creates ultracapacitors and battery electrodes that facilitate the integration of renewable energies into smart grids, thus promoting more efficient and sustainable electricity storage. The company is committed to minimizing the environmental impact of its manufacturing processes and emphasizes the importance of reusing, recovering, and recycling materials throughout the product lifecycle. With a dedicated team of 24 employees, NAWA Technologies operates a pilot production line to innovate new interface materials and storage devices that reduce carbon emissions and reliance on fossil fuels.

iFollow

Series A in 2021
iFollow is a manufacturer of collaborative autonomous robots designed to enhance operations in the logistics and retail sectors. The company specializes in developing autonomous mobile robots (AMRs) that automate the transport of heavy loads, addressing needs across various industries, including food, industrial, pharmaceutical, chemical, cosmetics, logistics, and retail. iFollow also offers a proprietary software suite that facilitates the optimization of intralogistics flows, enabling clients to improve productivity and efficiency in their operations. Through its innovative solutions, iFollow aims to transform traditional logistics processes by integrating advanced robotics technology.

Core for Tech

Venture Round in 2021
Core for Tech is a deep tech company focused on driving safety through measurement and prediction of drowsiness based on heart rate variability. The company develops technology that analyzes HRV to identify fatigue and predicts the driver's upcoming sleepiness level, enabling proactive safety decisions. Its solutions can be deployed via native vehicle sensors or retrofit systems, converting physiological data into actionable insights to reduce drowsiness-related risk on the road. By detecting drowsiness at an early stage before it becomes visible, Core for Tech aims to enhance on-road safety and support preventative driving interventions.

Micropep

Series A in 2021
Micropep Technologies is an agricultural biotechnology company founded in 2016 and based in Toulouse, France. The company specializes in the development of non-GMO bioherbicides and biostimulants utilizing its innovative miPEP technology, which harnesses naturally-occurring micro-peptides to regulate gene expression and enhance plant growth. Micropep focuses on four key development programs: germination, flowering, growth, and weed control, aiming to improve agricultural yields while maintaining the integrity of plant DNA. By leveraging the potential of these biomimetic peptides, Micropep seeks to provide effective solutions for managing plant genetics and enhancing resistance to diseases, thereby supporting sustainable farming practices.

Adionics

Seed Round in 2021
Adionics is a Paris-based technology company focused on saline water valorization and desalination. It develops and commercializes processes and chemicals for removing salts from saline sources, including AquaOmnes, a water-desalination technology that extracts salt from salty water to leave fresh water, and Flionex, an ion-absorbing liquid that binds salts. The company serves municipal water, power, oil and gas, and chemical markets. It also develops FLIONEX, a selective extractant for lithium salts, and pursues research to enable lithium recycling from batteries. Its saline water treatment platform uses a chemical-free liquid-liquid extraction with hot water stripping to recover lithium, valuable minerals, or remove impurities from brine, seawater and other saline sources, aiming for cost-effective, low-environmental impact solutions.

DessIA

Series A in 2021
DessIA develops artificial intelligence-augmented engineering software that automates engineering tasks. The platform provides AI-powered bots that assist engineers in the early stages of product development, quickly generating thousands of architectural options and identifying configurations that satisfy sustainability and profitability criteria. By reducing development lead times, the software helps automotive and mechanical engineers optimize designs and explore innovative approaches to engineering challenges.

Smartway

Series A in 2021
Smartway, founded in 2012 by two brothers, is dedicated to reducing both food and non-food waste while saving consumers money. The company addresses the issue of product wastage by developing a food waste management platform that utilizes artificial intelligence to assist in-store teams in identifying items nearing their expiry dates. Smartway facilitates the recycling of these products by enabling automatic discount labeling and streamlining administrative procedures related to food donation. This creates a beneficial relationship between consumers and distributors by highlighting affordable, soon-to-expire products in nearby stores. Smartway is expanding its presence across Europe and has received multiple awards for its contributions to sustainable development and innovative solutions in mass distribution.

Zéro-Gâchis

Venture Round in 2021
Zéro-Gâchis is an innovative service to save money and avoid food waste during your shopping. The objective of Zéro-Gâchis is to reduce food waste by assisting retailers in managing unsold items. Enabling everyone to take action to reduce food waste naturally brings forth strong values that drive the team's manner of working and its constant desire to improve service efficiency.

UroMems

Series B in 2021
UroMems is a medical device company dedicated to addressing specific clinical needs related to urinary conditions that significantly impact patients' quality of life. The company specializes in the design, development, and commercialization of active implantable medical devices. Its innovative approach aims to enhance existing surgical treatments by minimizing associated side effects and ensuring that patients receive appropriate care promptly. Through its commitment to improving treatment options, UroMems seeks to benefit a wide range of patients facing urinary health challenges.

AcuSurgical

Series A in 2021
AcuSurgical is a startup focused on advancing vitreo-retinal surgery through innovative technology. The company is developing a robotic surgical assistant specifically designed for retinal microsurgery, which aims to enhance the precision of eye operations. By providing surgeons with improved tools, AcuSurgical's device addresses common challenges faced in the treatment of retinal diseases, such as age-related macular degeneration. The technology helps filter hand tremors and enhances visualization during procedures, ultimately enabling better patient outcomes in the field of ophthalmic surgery.

PowerUp Technology

Venture Round in 2020
PowerUp Technology designs and markets battery management and optimization solutions for fleets of battery-powered equipment and consumer devices. Its smart chargers determine optimal charging conditions based on battery temperature, state of charge, and degradation, while software continuously monitors state of health, controls charging for individual batteries, and supports fleet management through a web application. The company's solutions apply to railway and other heavy equipment, backup power systems, portable tools, battery-powered personal vehicles, and consumer electronics. It provides lithium-ion battery analytics that diagnose health, enable dynamic charging to extend battery life, and process operational data to help clients identify asset risks and return-on-investment opportunities. PowerUp Technology was founded in 2017 and is based in Aulnay-sous-Bois, France.

Ynsect

Series C in 2020
Founded in 2011, Ynsect is a biotech company specializing in insect farming and processing. It produces feed for fish and poultry using insects as a sustainable protein source. The company also develops products for non-food applications such as organic fertilizers and bioenergy.

Microoled

Series A in 2020
Founded in 2007, Microoled specializes in the design, production, and marketing of OLED microdisplays for near-eye applications. These displays are used in outdoor optical equipment, night vision glasses, medical devices, and augmented reality (AR) glasses.

BeFC Bioenzymatic Fuel Cells

Seed Round in 2020
BeFC Bioenzymatic Fuel Cells is a company based in Grenoble, France, that specializes in the development of ecological devices, specifically paper-based bioenzymatic fuel cells. Founded in 2020, BeFC focuses on providing sustainable and eco-friendly energy solutions aimed at minimizing environmental impact. Their innovative technology features ultra-thin, flexible, and miniature fuel cells designed to replace traditional button or coin cell batteries, which are often difficult to recycle and environmentally harmful. By offering a safe alternative, BeFC facilitates the advancement of disposable and wearable medical devices, as well as low-power applications in health monitoring, logistics, and the Internet of Things (IoT). The company's approach not only addresses existing energy needs but also opens up new opportunities in various sectors.

UroMems

Series B in 2020
UroMems is a medical device company dedicated to addressing specific clinical needs related to urinary conditions that significantly impact patients' quality of life. The company specializes in the design, development, and commercialization of active implantable medical devices. Its innovative approach aims to enhance existing surgical treatments by minimizing associated side effects and ensuring that patients receive appropriate care promptly. Through its commitment to improving treatment options, UroMems seeks to benefit a wide range of patients facing urinary health challenges.

NAWA Technologies

Venture Round in 2020
NAWA Technologies specializes in developing advanced energy storage solutions, focusing on its innovative Ultra Fast Carbon Battery Technology. Founded in April 2013 and supported by over 15 years of research and development in nanomaterials, the company aims to enhance energy conversion, storage, transport, and efficiency using carbon, which is abundant and environmentally friendly. NAWA Technologies creates ultracapacitors and battery electrodes that facilitate the integration of renewable energies into smart grids, thus promoting more efficient and sustainable electricity storage. The company is committed to minimizing the environmental impact of its manufacturing processes and emphasizes the importance of reusing, recovering, and recycling materials throughout the product lifecycle. With a dedicated team of 24 employees, NAWA Technologies operates a pilot production line to innovate new interface materials and storage devices that reduce carbon emissions and reliance on fossil fuels.

Vulkam

Series A in 2020
Vulkam SAS is a microtechnology company based in Saint-Martin-d'Hères, France, specializing in the design and production of amorphous metal parts. Founded in 2017, Vulkam focuses on creating biocompatible amorphous metal alloys primarily composed of zirconium, copper, hafnium, nickel, and titanium. The company's innovative products serve various industries, including aerospace, automotive, biomedical, and microcomponents. Vulkam's micromechanical parts are notable for their small size and exceptional strength, offering performance comparable to established industry standards. By leveraging advanced materials science, Vulkam aims to set new benchmarks in metallurgy and metal processing, catering to the growing demand for high-performance, functional components in diverse applications.

Diabeloop

Series B in 2019
Diabeloop is a medical device company based in Grenoble, France, specializing in innovative solutions for diabetes management. Founded in 2015, the company focuses on developing a closed-loop system that automates insulin delivery for individuals with type 1 diabetes. Its AI-based blood sugar monitoring device integrates a sensor that continuously measures glucose levels, a pump that administers insulin, and a smartphone application that connects these components through an embedded algorithm. This technology aims to enhance the treatment experience by reducing the mental burden on patients, allowing them to manage their condition more effortlessly and live their lives with greater freedom.

Remedee Labs

Series A in 2019
Remedee Labs SAS is a French company founded in 2016, dedicated to developing innovative solutions for chronic pain management. The company has created the Microelectronic Endorphin Trigger (MEET), a personal endorphin stimulator that facilitates on-demand stimulation of the body’s natural endorphins to alleviate pain. Drawing on a decade of pre-clinical and clinical research, Remedee Labs aims to improve the quality of life for the 1.5 billion people worldwide suffering from chronic pain, particularly focusing on conditions such as fibromyalgia. By collaborating with medical practitioners, the company offers a patient-centered digital service platform that enhances the accessibility and effectiveness of endorphin-stimulation therapy for personal healthcare. As it continues to evolve, Remedee Labs plans to expand its platform to address additional chronic pain conditions, positioning itself as a leader in neuromodulation technology for pain management.

Cailabs

Series B in 2019
CAILabs SAS is a French deep tech company headquartered in Rennes, specializing in the design, development, and production of photonic solutions aimed at optimizing light utilization in various applications. Established in 2013, CAILabs focuses on innovative optical components, particularly through its patented Multi-Plane Light Conversion (MPLC) technology. The company provides a range of products, including mode multiplexers, light converters, and laser beam shaping solutions tailored for the telecommunications and industrial laser sectors. Its offerings are designed to enhance the performance of fiber optic networks and laser material processing, addressing critical challenges such as atmospheric turbulence and the need for efficient signal multiplexing. CAILabs aims to leverage its expertise and technological innovations to create reliable and cost-effective solutions for clients in the photonics industry.

SCINTIL Photonics

Seed Round in 2019
SCINTIL Photonics is a fabless company focused on silicon photonics, developing silicon photonic integrated circuits. It combines silicon and indium phosphide materials using wafer-scale bonding to create fully integrated photonic circuits, including multi-wavelength lasers, waveguides, wavelength filters, and photodetectors, designed for high-speed data communication. The company relies on commercial silicon foundry processes and offers co-packaged and pluggable formats to enhance AI data center bandwidth and performance. Headquartered in Grenoble, France.

Keranova

Venture Round in 2019
Founded in 2015, Keranova specializes in designing and developing innovative surgical equipment for ophthalmologic indications involving the anterior segment of the eye. The company's patented technology aims to advance ophthalmic procedures by reducing manual intervention through automated instruments.

Robocath

Venture Round in 2019
Founded in 2009, Robocath specializes in designing, developing, and commercializing robotic solutions for treating cardiovascular diseases. Its flagship product, R-One™, is a robotic system for coronary angioplasty that enhances procedure safety and precision while complementing manual interventions. The company aims to become the global leader in vascular robotics.

Traxens

Series C in 2019
Traxens is a provider of supply chain tracking services that offers comprehensive data and analytics to enhance visibility into container transport and logistics. The company focuses on delivering precise and timely information on containers and their transporters, enabling stakeholders in multi-modal transport to improve operational efficiency, reduce costs, and optimize investments. Through a dedicated three-year research and development program, Traxens has developed advanced technology for cost-effective, durable, and autonomous devices capable of capturing and transmitting real-time data from anywhere in the world. This innovative approach allows Traxens to transform logistics data into actionable insights, benefiting a wide range of customers in the supply chain industry.

Microphyt

Venture Round in 2019
Microphyt is a company focused on researching, developing, producing, and marketing natural algae-based products. It specializes in creating bioactive dietary supplements aimed at promoting weight loss and supporting brain health. The company utilizes an industrial-scale supply of microalgae biomass and extracts, ensuring the preservation of cell integrity while achieving commercial quantities of slow-growing or biofilm-forming species. This approach enables Microphyt to effectively cater to the demands of healthcare industries, particularly in the personal care and food sectors.

NAWA Technologies

Venture Round in 2019
NAWA Technologies specializes in developing advanced energy storage solutions, focusing on its innovative Ultra Fast Carbon Battery Technology. Founded in April 2013 and supported by over 15 years of research and development in nanomaterials, the company aims to enhance energy conversion, storage, transport, and efficiency using carbon, which is abundant and environmentally friendly. NAWA Technologies creates ultracapacitors and battery electrodes that facilitate the integration of renewable energies into smart grids, thus promoting more efficient and sustainable electricity storage. The company is committed to minimizing the environmental impact of its manufacturing processes and emphasizes the importance of reusing, recovering, and recycling materials throughout the product lifecycle. With a dedicated team of 24 employees, NAWA Technologies operates a pilot production line to innovate new interface materials and storage devices that reduce carbon emissions and reliance on fossil fuels.

NH TherAguix

Series A in 2019
NH TherAguix SAS is a clinical-stage pharmaceutical company based in Villeurbanne, France, focused on the development of nanomedicines for cancer treatment. The company specializes in creating innovative therapeutics that enhance radiotherapy for solid tumors. Its lead product, AGuIX, is a theranostic nanoparticle designed to improve the localization of tumors and optimize radiation therapy outcomes. By facilitating intravenous administration, AGuIX enables healthcare professionals to determine the best timing for irradiation, targets tumor tissues more effectively, and minimizes adverse effects on healthy tissues by reducing radiation doses. Founded in 2015, NH TherAguix is dedicated to advancing cancer treatment through its pioneering approach to combining imaging and radiotherapy.

Diota

Series B in 2019
Diota is a company based in Massy, France, specializing in augmented reality (AR) software solutions tailored for industrial applications. Founded in 2009, the company focuses on integrating digital data with human operators to enhance the efficiency of complex industrial processes. Its flagship product, DiotaPlayer, facilitates the use of AR across various industrial sectors, including manufacturing, aerospace, automotive, and oil and gas. The software allows users to browse, interact with, check, report, and track information seamlessly within existing hardware and software environments. Diota’s solutions are compatible with multiple devices, such as tablets and head-mounted displays, making them versatile for different operational needs. Additionally, the company offers consulting, technical support, and training services to optimize the implementation of its technologies. Diota's client base includes major industry players such as Safran Group, Dassault Aviation, and Renault, positioning it as a key contributor to the digital transformation of the industrial landscape in Europe.

Carthera

Series B in 2018
Carthera is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices for treating brain disorders. Its proprietary device, SonoCloud®, is an intracranial ultrasound implant that, when used in conjunction with an intravenous microbubble agent, temporarily opens the blood-brain barrier. This mechanism significantly enhances the delivery of therapeutic molecules to the brain, potentially providing new treatment options for debilitating neurological conditions. Through its technology, Carthera aims to enable healthcare professionals to address challenging brain disorders more effectively.

Blue Valet

Venture Round in 2018
Blue Valet, founded in 2015 and based in Mérignac, France, specializes in online valet parking services at airports and train stations. The company offers a convenient platform for travelers to book valet services, ensuring a hassle-free experience when accessing major mobility hubs. Blue Valet aims to provide an economical and efficient solution for both leisure and business travelers, allowing them to navigate their journeys without stress or complications.

iskn

Venture Round in 2018
iskn is a consumer electronics company that develops and markets the slate for smart drawing. iskn is the leading pioneer in AUGMENTED INTERACTION thanks to its technology representing 24 international patents based on 60 years of deep tech R&D expertise in magnetometry at the world-renowned CEA LETI. The company’s primary mission consists in enriching the experience and facilitate interaction with the digital world by bringing back emotion through the use of day-to-day physical objects. This has already come to life by turning any pencil into a digital one with the widely adopted SLATE, and the yet to come disruptive REPAPER graphic tablet.

Terakalis

Seed Round in 2018
Terakalis is a company that specializes in the development of non-destructive testing equipment for the analysis and control of materials and industrial processes. Established through a technological partnership with the Charles Coulomb laboratory in 2012, Terakalis focuses on TeraHertz electromagnetic waves, which range from 100 GHz to 10 THz. The company's offerings include a variety of both generic and custom-made products and systems designed to inspect materials for internal defects and to characterize their physical and chemical properties. By providing integrated line-of-production equipment and portable alternatives, Terakalis enhances operational efficiency for businesses across various sectors.

Prophesee

Series B in 2018
Prophesee develops neuromorphic vision systems that mimic the human eye's functionality. Its patented sensors and AI algorithms enable unprecedented speed (>10,000 fps), dynamic range (>120dB), data volume reduction (10x to 1000x), and power efficiency (<10 mW). Prophesee serves clients in autonomous driving, mobile devices, IoT, and industry sectors. Founded in Paris in 2014 by Ryad Benosman, Bernard Gilly, Christoph Posch, and Luca Verre, the company is backed by leading international investors.

mirSense

Seed Round in 2018
mirSense develops Quantum Cascade Lasers (QCL) and QCL-based spectrometer modules for gas analysis. Its products enable industries and defense sectors to monitor and control gas emissions, improve air quality, and enhance medical treatment accuracy.

En Voiture Simone

Venture Round in 2018
En Voiture Simone is an online driving school that launched in 2015, dedicated to connecting students with qualified driving instructors. The platform allows learners to find instructors who meet their specific needs, facilitating a personalized and effective learning experience for obtaining a driving license. By leveraging technology, En Voiture Simone aims to simplify the process of finding the right driving instructor, thus supporting students in achieving their driving goals.

Aledia

Series C in 2018
Founded in 2011, Aledia specializes in the development and manufacturing of innovative light-emitting diodes (LEDs) based on a unique 3D architecture using gallium-nitride-on-silicon microwires. This technology enables efficient, brighter, and cost-effective displays for various applications such as general lighting, automotive, displays, smartphones, smartwatches, tablets, and laptops.

Upmem

Seed Round in 2017
Upmem develops innovative Processing-In-Memory (PIM) solutions for datacenters, accelerating data-intensive applications by up to 10 times. Their technology reduces off-chip data movements, enhancing efficiency and reducing energy consumption.

SeqOne Genomics

SeqOne S.A.S. is a company based in Montpellier, France, that specializes in developing genomic data analysis software for the healthcare industry. Founded in 2017, SeqOne's platform offers end-to-end management of next-generation sequencing (NGS) and bioinformatics data, providing advanced tools for analyzing complex genomic information. The software is designed to deliver medically actionable results across various areas, including oncology, hematological diseases, rare diseases, genetic screening, and hereditary conditions. By addressing the challenges associated with analyzing rich genomic data, SeqOne aims to enhance the accessibility and effectiveness of genomic medicine, thereby facilitating improved treatment options for patients. The company serves both private and public healthcare sectors, contributing to the ongoing transformation of healthcare through the integration of genomic insights.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.